Prometheus and related cases have changed the landscape of U.S. personalized medicine. However, that landscape has not been drastically narrowed as some have suggested.
To patent or not to patent. That is the question … at least it has been for the past two years as the courts have been offering up differing opinions on the matter.
The Federal Circuit has suggested it may hold firm in its earlier decision to allow isolated human genes to be patented.